E

Alzai Health Corp. ALZI.V

TSX
Recommendation
Dividend Power Score
Prev Close
Volume
--
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Alzai Health Corp. (TSX Venture Exchange: ALZI) is a Canadian healthcare and technology-focused company operating in the digital health and cognitive care sector. Based on publicly available corporate disclosures and exchange filings, the company’s activities have centered on developing and commercializing healthcare-related technologies and services associated with neurological health, cognitive assessment, and patient-oriented digital platforms. Public information available through Canadian market disclosures indicates that the company has positioned itself within the broader health technology and aging-care markets, although detailed operational disclosures remain limited compared with larger publicly traded healthcare companies.

The company’s strategic positioning appears tied to the growing demand for cognitive health monitoring, preventative healthcare technologies, and data-enabled patient engagement tools. Available public records indicate that Alzai Health Corp. has evolved through corporate restructuring and early-stage business development initiatives typical of venture-listed healthcare issuers. However, certain operational details, historical milestones, and long-term commercial performance metrics remain limited in publicly accessible filings. Data inconclusive based on available public sources regarding the company’s full historical evolution and market share.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Thursday, August 27, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Oct 19 and 23 (est)

Price History

Loading...
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
416 862 4351
Address
22 Adelaide Street West
Suite 3400
Toronto, ON M5H 4E3
Country
Year Founded

Headlines

There are no news to display.